ABSTRACT
In Korea, there was a big outbreak of aseptic meningitis in 1993. Six clinical isolates of enterovirus were obtained from patients with aseptic meningitis and were identified as echovirus type 9 by serotyping with a pool of neutralizing antisera. For molecular characterization of the isolates, the nucleotide sequences of 5'-noncoding region (NCR), VP4, VP2, VP1, 2A and 2C regions of the isolates were compared with the corresponding regions of echovirus type 9 Hill and Barty strains. Unlike Hill strain, Barty strain contained a C-terminal extension to the capsid protein VP1 with an RGD (argnine-glycine-aspartic acid) motif. To determine whether similar structural features were present in our isolates, their nucleotide sequences including the VP1 region were analyzed. All isolates exhibited the VP1 extension with the RGD motif. We concluded the Korean isolates in the year of 1993 as the echovirus type 9 Barty strain although the isolates showed 15-20% nucleotide sequence differences in the several genomic regions.
Subject(s)
Humans , 5' Untranslated Regions , Base Sequence , Capsid/genetics , Comparative Study , Cysteine Endopeptidases/genetics , Echovirus 9/genetics , Genome, Viral , Meningitis, Aseptic/virology , Molecular Sequence Data , RNA Helicases/genetics , Genetic VariationABSTRACT
1. Plant viruses can only enter their host through a wounded plant cell. Once in the cytoplasm, the virion must be disassembled, and for certain viruses with a "+" RNA genome, cotranslational disassembly of virus particles has been described. 2. Subsequent to viral protein synthesis which requires the host translational machinery, the "+" RNA genome is replicated in the cytoplasm. Viral genome amplification requires at least one viral-coded non-structural protein in conjunction with one or more host factors. 3. Early events in virus infection can be studied in systems that hinder these events. This is the case of natural hosts that are resitant to viruses: mutant viruses which overcome such resistance have been described. It is also the case of genetically engineered plants that are protected from virus infection. Both types of systems should help in determining the mode of interaction involved, and possibly also the host factor(s) involved in the various steps of virus infection
Subject(s)
Plant Viruses/genetics , RNA Viruses/genetics , Capsid/genetics , Genes, Viral , Genome, Viral , Protein Biosynthesis , RNA Viruses/genetics , Virus ReplicationABSTRACT
We have cloned and sequenced the L1 and L2 genes from human papillomavirus type 16 (HPV16) DNA-containing cervical cytology samples collected from the U.K. and Trinidad. Samples containing high copy numbers of HPV16 DNA were selected as being likely to contain fully functional virus DNA molecules in an episomal state, rather than in an integrated and possibly altered state. In comparison with the perviously published sequence of HPV16 isolated from an invasive cancer a variety of differences were detected in both L1 and L2. The pattern of changes appears to be different in samples from the two geographic regions. One of the differences (resulting in D at position 202 of the L1 protein) reported recently to be functionally important for virus particle assembly was found to occur in all the samples examined. Variations in L1 found within known immunoreactive regions or hydrophobic domains should be taken into account in design of prophylactic vaccines for HPV16 based on virus-like particles. All variations within L2 protein were found in hydrophilic domains in the carboxy-terminal half of L2. These positions were highly variable among other types of papillomavirus and are located outside the known L2 immunoreactive region. (AU)
Subject(s)
Humans , Female , Capsid/genetics , Alphapapillomavirus/genetics , /microbiology , Tumor Virus Infections/microbiology , Genetic Variation/genetics , Amino Acids/analysis , Capsid/chemical synthesis , Uterine Cervical Dysplasia/microbiology , Uterine Cervical Neoplasms/microbiology , Cloning, Molecular , Consensus Sequence/genetics , DNA, Viral/isolation & purification , Genes, Viral , United Kingdom , Oncogene Proteins, Viral/chemical synthesis , /genetics , Point Mutation/genetics , Sequence Analysis, DNA , Trinidad and TobagoABSTRACT
1. cDNA recombinants containing the VP3 and VP1 sequences of foot-and-mouth disease virus were isolated and the VP3-VP1 sequence was reconstructed. 2. The reconstructed VP3-VP1 sequence was subcloned into expression vector pEX31b and a fusion protein of about 62,000 Da was expressed. 3. When injected into mice, the fusion protein was able to elicit the production of antibodies that recognized viral VP1 and VP3. 4. Antibodies present in sera from mice immunized with VP3-VP1 protein did not neutralize the foot-and-mouth disease virus in vitro
Subject(s)
Animals , Mice , Antibodies, Viral/biosynthesis , Aphthovirus/genetics , Escherichia coli/genetics , Viral Fusion Proteins/isolation & purification , Aphthovirus/immunology , Blotting, Western , Capsid/genetics , Capsid/immunology , Capsid/isolation & purification , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Neutralization Tests , Viral Fusion Proteins/genetics , Viral Fusion Proteins/immunologyABSTRACT
The nucleotide sequences encoding the capsid protein VP1 were determined for the wild polioviruses of serotypes 1 and 3 endemic to the northeastern region of Brazil. Compared with the corresponding Sabin vaccine strain sequences, the wild isolates differed at 20%(type 1) and 22%(type 3) of their nucleotide positions, and in 7%(type 1) and 11%(type 3) of their amino acid residues. The highest degree of amino acid heterogeneity occurred within the amino-terminal residues of the VP1 proteins. Intratypic amino acid differences also occurred in VP1 surface residues that form parts of antigenic sites for neutralizing antibodies